KeyBanc raised the firm’s price target on HCA Healthcare (HCA) to $500 from $475 and keeps an Overweight rating on the shares. 2025 was a difficult year for investors in Healthcare Services, the firm says. KeyBanc thinks 2026 may bring a less positive backdrop for Hospitals and incrementally better backdrop for managed care organizations and value-based care.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare promotes Erica Rossitto to senior VP and chief nurse executive
- HCA Healthcare price target raised to $452 from $431 at Wells Fargo
- HCA Healthcare price target raised to $503 from $486 at Bernstein
- HCA Healthcare price target lowered to $495 from $520 at Truist
- HCA Healthcare price target raised to $520 from $505 at Mizuho